Identification and Molecular Modification of Staphylococcus aureus Bacteriophage Lysin LysDZ25
ACS Infectious Diseases · 10.03.2023 · 9 (3) · 497-506
DOI: 10.1021/acsinfecdis.2c00493 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 14.02.2023. Verfasst von Yan Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Government of Shandong Province, Shandong Academy of Agricultural Sciences.
Abstract (Originalsprache)
With the continuous emergence and spread of drug-resistant and multi-drug-resistant Staphylococcus aureus, traditional antibiotic treatment has gradually lost its effect. There is an urgent need to develop and study new and effective bio-green inhibitors to control S. aureus. In this study, the S. aureus phage DZ25 was isolated from milk and the lysin LysDZ25 with excellent tolerance to serum and NaCl solution was identified. Subsequently, to improve the lytic activity and thermal stability of LysDZ25, RoseTTAFold was used to construct three-dimensional (3D) structures, molecular dynamics (MD) simulation was used for conformational acquisition, and the MDL strategy previously developed in our lab was used to rationally design variants. After two rounds of rational design, the optimal variant with improved thermal stability, S333V/N245R/D299L, was obtained, and its half-life time was 4.0-fold that of wild-type LysDZ25. At 37, 40, 45, and 50 °C, the lytic activity of the optimal triple-point variant S333V/N245R/D299L was increased by 17.3-, 26.7-, 20.2-, and 50.1-fold compared with that of the wild-type LysDZ25, respectively. Finally, cell count was used to evaluate the lytic activity, and the results showed that the optimal variant S333V/N245R/D299L could drop about 3.5 log 10 values compared with the control and about 2.6 log 10 values compared with the wild-type LysDZ25.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
- Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan 250100, China.
ORCID-Profile: Qingbin Li, Qingsheng Qi
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Government of Shandong Province
- Shandong Academy of Agricultural Sciences
Zitieren
APA
Chang, Y., Li, Q., Zhang, S., Zhang, Q., Liu, Y., Qi, Q., & Lu, X. (2023). Identification and Molecular Modification of Staphylococcus aureus Bacteriophage Lysin LysDZ25. ACS Infectious Diseases, 9(3), 497-506. https://doi.org/10.1021/acsinfecdis.2c00493
Vancouver
Chang Y, Li Q, Zhang S, Zhang Q, Liu Y, Qi Q, et al. Identification and Molecular Modification of Staphylococcus aureus Bacteriophage Lysin LysDZ25. ACS Infectious Diseases. 2023;9(3):497-506. doi:10.1021/acsinfecdis.2c00493
BibTeX
@article{Chang2023,
author = {Chang, Yan and Li, Qingbin and Zhang, Shuhang and Zhang, Qing and Liu, Yuqing and Qi, Qingsheng and Lu, Xuemei},
title = {Identification and Molecular Modification of Staphylococcus aureus Bacteriophage Lysin LysDZ25},
journal = {ACS Infectious Diseases},
year = {2023},
volume = {9},
number = {3},
pages = {497--506},
doi = {10.1021/acsinfecdis.2c00493}
}
EUVIMED